Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 1.00 |
| ▸ | CYP2D6 | P10635 | 1/20 | 1.00 |
| ▸ | CYP2C9 | P11712 | 1/20 | 1.00 |
| ▸ | ALOX15 | P16050 | 1/20 | 1.00 |
| ▸ | MAPK1 | P28482 | 1/20 | 1.00 |
| ▸ | FYN | P06241 | 1/20 | 0.64 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Pnu-99194A SCHEMBL29462288 | 1.00 | ALDH1A1 (1.00) | ALDH1A1CYP2D6CYP2C9ALOX15MAPK1 | |
| Pnu-99194A SCHEMBL29390413 | 0.98 | ALDH1A1 (0.97) | ALDH1A1CYP2D6CYP2C9ALOX15MAPK1 | |
| Pnu-99194A SCHEMBL8443806 | 0.98 | ALDH1A1 (0.97) | ALDH1A1CYP2D6CYP2C9ALOX15MAPK1 | |
| SCHEMBL8689915 | 0.90 | ALDH1A1 (0.81) | ALDH1A1CYP2D6CYP2C9ALOX15MAPK1 | |
| Pnu-99194A SCHEMBL29725518 | 0.87 | ALDH1A1 (1.00) | ALDH1A1CYP2D6CYP2C9ALOX15MAPK1 | |
| SCHEMBL8689145 | 0.86 | ALDH1A1 (0.75) | ALDH1A1CYP2D6CYP2C9ALOX15MAPK1 | |
| SCHEMBL8693001 | 0.85 | ALDH1A1 (0.73) | ALDH1A1CYP2D6CYP2C9ALOX15MAPK1 | |
| SCHEMBL8691655 | 0.85 | ALDH1A1 (0.73) | ALDH1A1CYP2D6CYP2C9ALOX15MAPK1 | |
| SCHEMBL8689188 | 0.85 | ALDH1A1 (0.73) | ALDH1A1CYP2D6CYP2C9ALOX15MAPK1 | |
| SCHEMBL8692999 | 0.84 | ALDH1A1 (0.71) | ALDH1A1CYP2D6CYP2C9ALOX15MAPK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210330609-A1 | BINGE BEHAVIOR REGULATORS | CLEARMIND LABS CORP. (CA) | 2021-10-28 | — | — | US | disclosed |
| US-9034798-B2 | Capture compounds, collections thereof and methods for analyzing the proteome and complex compositions | CAPROTEC BIOANALYTICS GMBH (DE) | 2015-05-19 | — | — | US | disclosed |
| US-8569481-B2 | Capture compounds, collections thereof and methods for analyzing the proteome and complex compositions | PHARMACEUTICALS, INC. (US) | 2013-10-29 | — | — | US | disclosed |
| WO-2011140607-A1 | A METHOD OF TREATMENT AND DIAGNOSIS | KEATING CHARLOTTE L (AU) | 2011-11-17 | — | — | WO | disclosed |
| WO-2011140608-A1 | NEUROPSYCHOPHARMACOLOGICAL TREATMENT REGIMES FOR TREATING PSYCHOLOGICAL DISORDERS | KEATING CHARLOTTE L (AU) | 2011-11-17 | — | — | WO | disclosed |
| US-20110118136-A1 | Capture compounds, collections thereof and methods for analyzing the proteome and complex compositions | KOESTER HUBERT | 2011-05-19 | — | — | US | disclosed |
| US-20100298168-A1 | Capture compounds, collections thereof and methods for analyzing the proteome and complex compositions | HK PHARMACEUTICALS, INC. | 2010-11-25 | — | — | US | disclosed |
| US-20100248264-A1 | Capture compounds, collections thereof and methods for analyzing the proteome and complex compositions | HK PHARMACEUTICALS, INC. | 2010-09-30 | — | — | US | disclosed |
| EP-0712387-B1 | 2-AMINOINDANS AS SELECTIVE DOPAMINE D3 LIGANDS | UPJOHN CO (US) | 1999-12-08 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110118136-A1 | Capture compounds, collections thereof and methods for analyzing the proteome and complex compositions | PTMS, QPCTL, SRMS | ALDH1A1 4360/4885CYP2D6 4323/4885CYP2C9 4064/4885 |
| US-20210330609-A1 | BINGE BEHAVIOR REGULATORS | GABRB3, GABRB2, GABRB1 | ALDH1A1 847/4885CYP2D6 2059/4885CYP2C9 3171/4885 |
| US-20100298168-A1 | Capture compounds, collections thereof and methods for analyzing the proteome and complex compositions | CHLSN, PTMS, SRMS | ALDH1A1 4064/4885CYP2D6 4202/4885CYP2C9 4293/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.